Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Hull
Jeanine Walenga

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 17, 2011
Contaminants in heparinRussell Hull, Jeanine Walenga
International Angiology : a Journal of the International Union of Angiology|May 11, 2018
Medical management of stable peripheral artery disease: the COMPASS trial. Perspectives from a vascular standpointEduardo Ramacciotti, Valter Castelli, Jeanine Walenga, et al.
Drug Safety|June 20, 2003
Benefit-risk assessment of treatments for heparin-induced thrombocytopeniaHarry Messmore, Walter Jeske, William Wehrmacher, et al.
Seminars in Respiratory and Critical Care Medicine|February 28, 2008
The future of anticoagulationDebra A Hoppensteadt, Walter Jeske, Jeanine Walenga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 27, 2009
Oral antithrombotic inhibitors: dabigatran etexilate, meeting an unmet need?Russell Hull
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 23, 2011
Essay for the CIHR/CMAJ award: the role of low-molecular-weight heparin therapy venous thromboembolismRussell Hull
Lancet (London, England)|March 9, 2010
Apixaban to prevent venous thromboembolism after knee replacementJawed Fareed, Russell Hull
Archives of Internal Medicine|October 20, 2017
Heparin Side Effects-ReplyRussell Hull, Jack Hirsh
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 13, 2012
Value of patient self-assessment in the diagnosis and monitoring of post-thrombotic syndrome: the Patient-Tracked Symptoms questionnaireRussell Hull, Penny Butcher
Hematology/Oncology Clinics of North America|January 11, 2005
Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical useRodger L Bick, Eugene P Frenkel, Jeanine Walenga, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 17, 2011
Contaminants in heparinRussell Hull, Jeanine Walenga
International Angiology : a Journal of the International Union of Angiology|May 11, 2018
Medical management of stable peripheral artery disease: the COMPASS trial. Perspectives from a vascular standpointEduardo Ramacciotti, Valter Castelli, Jeanine Walenga, et al.
Drug Safety|June 20, 2003
Benefit-risk assessment of treatments for heparin-induced thrombocytopeniaHarry Messmore, Walter Jeske, William Wehrmacher, et al.
Seminars in Respiratory and Critical Care Medicine|February 28, 2008
The future of anticoagulationDebra A Hoppensteadt, Walter Jeske, Jeanine Walenga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 27, 2009
Oral antithrombotic inhibitors: dabigatran etexilate, meeting an unmet need?Russell Hull
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 23, 2011
Essay for the CIHR/CMAJ award: the role of low-molecular-weight heparin therapy venous thromboembolismRussell Hull
Lancet (London, England)|March 9, 2010
Apixaban to prevent venous thromboembolism after knee replacementJawed Fareed, Russell Hull
Archives of Internal Medicine|October 20, 2017
Heparin Side Effects-ReplyRussell Hull, Jack Hirsh
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 13, 2012
Value of patient self-assessment in the diagnosis and monitoring of post-thrombotic syndrome: the Patient-Tracked Symptoms questionnaireRussell Hull, Penny Butcher
Hematology/Oncology Clinics of North America|January 11, 2005
Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical useRodger L Bick, Eugene P Frenkel, Jeanine Walenga, et al.
Pageof 5